SARS-CoV-2 infection in hematological patients during allogenic stem cell transplantation: A double case report.

异基因干细胞移植过程中血液病患者的 SARS - CoV - 2 感染 ： 一例病例报告。

• 发表时间: Jul 2021
• 来源期刊: Clin Case Rep
• DOI: 10.1002/ccr3.4439
• PMID: 34295477
• 文章类型: Case Reports
• 作者列表: Alexandra VU,Sebastian W,Nathalie M,Angela L,Jean-Corentin S,Chloé S

关键词: Aplasia; SARS‐CoV‐2; acute myeloid leukemia

Abstract

Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID-19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.

摘要

尽管由于急性髓细胞白血病的预处理化疗而导致严重的免疫抑制，COVID-19没有导致临床恶化或死亡，因此提出了免疫抑制治疗对临床病程演变的影响的问题。